Key facts
- It has raised $3.5M; the latest was PE Growth/Expansion ($10K) in Aug 2025.
- Notable investors include Summit Partners, Lauxera Capital Partners, Accelmed.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Veranex
- ·The full record, as it builds
Funding rounds
No funding rounds for Veranex are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Veranex
Provider of technology-enabled services dedicated to the medical technology industry. The company offers a variety of services including design and engineering, regulatory, clinical and market access services for medical devices, diagnostics, companion diagnostics, digital health and drug delivery, enabling clients to accelerate speed to market and market viability, control development costs and mitigate risk.
- Sector
- Healthcare
- HQ
- Raleigh, NC, United States
- Founded
- 2021
- Employees
- 1,300
- Website
- veranex.com/
- Ownership
- Privately Held (backing)
Veranex doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Veranex shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Veranex in its N-PORT filings yet. We sweep new filings monthly.